Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando A Batista

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Analytical Methods : Advancing Methods and Applications|March 12, 2024
Evaluation of organo-vermiculites as sorbent phases for solid-phase extraction of ibuprofen from waterLuis Fernando A Batista, Sara Renata S Gonçalves, Carolina D Bressan, et al.
Expert Opinion on Drug Discovery|January 22, 2020
New directions in antimalarial target validationFernando A Batista, Benjamin Gyau, Juliana F Vilacha, et al.
International Journal of Biological Macromolecules|January 4, 2020
A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosaJoko P Wibowo, Fernando A Batista, Niels van Oosterwijk, et al.
ACS Infectious Diseases|March 5, 2020
Molecular Target Validation of Aspartate Transcarbamoylase from <i>Plasmodium falciparum</i> by Torin 2Soraya S Bosch, Sergey Lunev, Fernando A Batista, et al.
Plos One|April 26, 2018
Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitroSergey Lunev, Sabine Butzloff, Atilio R Romero, et al.
Biochemical and Biophysical Research Communications|February 25, 2018
Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylaseSergey Lunev, Soraya S Bosch, Fernando A Batista, et al.
Microbiologyopen|March 2, 2019
Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparumFernando A Batista, Soraya S Bosch, Sabine Butzloff, et al.
Acta Crystallographica. Section D, Structural Biology|July 10, 2023
3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitorMariano Martinez, Fernando A Batista, Manon Maurel, et al.
Scientific Reports|July 15, 2022
Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetesZayana M Al-Dahmani, Xiaogang Li, Lucas M Wiggenhauser, et al.
Chemmedchem|January 20, 2025
Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic ConstraintsAnna K Puszko, Fernando A Batista, Abdelaziz Ejjoummany, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Analytical Methods : Advancing Methods and Applications|March 12, 2024
Evaluation of organo-vermiculites as sorbent phases for solid-phase extraction of ibuprofen from waterLuis Fernando A Batista, Sara Renata S Gonçalves, Carolina D Bressan, et al.
Expert Opinion on Drug Discovery|January 22, 2020
New directions in antimalarial target validationFernando A Batista, Benjamin Gyau, Juliana F Vilacha, et al.
International Journal of Biological Macromolecules|January 4, 2020
A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosaJoko P Wibowo, Fernando A Batista, Niels van Oosterwijk, et al.
ACS Infectious Diseases|March 5, 2020
Molecular Target Validation of Aspartate Transcarbamoylase from <i>Plasmodium falciparum</i> by Torin 2Soraya S Bosch, Sergey Lunev, Fernando A Batista, et al.
Plos One|April 26, 2018
Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitroSergey Lunev, Sabine Butzloff, Atilio R Romero, et al.
Biochemical and Biophysical Research Communications|February 25, 2018
Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylaseSergey Lunev, Soraya S Bosch, Fernando A Batista, et al.
Microbiologyopen|March 2, 2019
Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparumFernando A Batista, Soraya S Bosch, Sabine Butzloff, et al.
Acta Crystallographica. Section D, Structural Biology|July 10, 2023
3D structures of the Plasmodium vivax subtilisin-like drug target SUB1 reveal conformational changes to accommodate a substrate-derived α-ketoamide inhibitorMariano Martinez, Fernando A Batista, Manon Maurel, et al.
Scientific Reports|July 15, 2022
Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetesZayana M Al-Dahmani, Xiaogang Li, Lucas M Wiggenhauser, et al.
Chemmedchem|January 20, 2025
Towards Improved Peptidic α-Ketoamide Inhibitors of the Plasmodial Subtilisin-Like SUB1: Exploration of N-Terminal Extensions and Cyclic ConstraintsAnna K Puszko, Fernando A Batista, Abdelaziz Ejjoummany, et al.
Pageof 2